Population pharmacokinetics of brexpiprazole in Japanese healthy subjects and patients with schizophrenia

Related articles

1. Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials

   This article has 35 authors:

   1. Bernard Ngara
   2. Belén P Solans
   3. Eunsol Yang
   4. Pieter Van Brantegem
   5. Lorenzo Guglielmetti
   6. Francis Varaine
   7. Maelenn Gouillou
   8. Carole D. Mitnick
   9. Allison N. LaHood
   10. Michael L. Rich
   11. Kwonjune J. Seung
   12. Lubbe Wiesner
   13. Loren Hans
   14. Rina Swart
   15. Amanzhan Abubakirov
   16. Kanat Khazhidinov
   17. Anel Belgozhanova
   18. Stephane Mpinda
   19. Sesomo Mohale
   20. David Holtzman
   21. Dante Vargas Vásquez
   22. Fanny García Velarde
   23. Sergio Mucching-Toscano
   24. Annum Aftab
   25. Mahnoor S. Arshad
   26. Azka Ashraf
   27. Luong V. Dinh
   28. Hanh T.T. Nguyen
   29. Ha T.T. Phan
   30. Sean Wasserman
   31. Nelisiwe Ntuli
   32. Radojka M. Savic
   33. Helen McIlleron
   34. Gustavo E. Velásquez
   35. PandrTB Study Group

2. Genotype-guided isoniazid dosing harmonizes drug exposure in 3HP tuberculosis preventive therapy

   This article has 15 authors:

   1. Kesia Esther da Silva
   2. Samuel Sarkodie
   3. Karina Marques
   4. Patricia Vieira
   5. Roberto Dias de Oliveira
   6. Paulo César Pereira dos Santos
   7. Marco Antonio Moreira Puga
   8. Allyson Guimarães Costa
   9. João Paulo Gregorio Machado
   10. Renata Spener-Gomes
   11. Eunsol Yang
   12. Rada Savic
   13. Marcelo Cordeiro-Santos
   14. Julio Croda
   15. Jason R. Andrews

3. A pharmacokinetics-informed ODE extrapolates long-term fenofibrate transcriptomic responses

   This article has 4 authors:

   1. Yixuan Gao
   2. Zheng Zhang
   3. Yu Li
   4. Jian’en Qiu